Role of cyclophilin B in prolactin signal transduction and nuclear retrotranslocation
- PMID: 10935542
- DOI: 10.1210/mend.14.8.0508
Role of cyclophilin B in prolactin signal transduction and nuclear retrotranslocation
Abstract
The pleiotropic actions of PRL are necessary for mammary growth and differentiation and in vitro lymphoid proliferation. The proximal action of this ligand is mediated by its cell surface receptor via associated networks. PRL action, however, is also associated with the internalization and translocation of this hormone into the nucleus. To delineate the mechanism of this retrotranslocation, a yeast two-hybrid screen was performed and revealed an interaction between PRL and cyclophilin B (CypB). CypB is a peptidyl prolyl isomerase (PPI) found in the endoplasmic reticulum, extracellular space, and nucleus. The interaction between CypB and PRL was subsequently confirmed in vitro and in vivo through the use of recombinant proteins and coimmunoprecipitation studies. The exogenous addition of CypB potentiated the 3H-thymidine incorporation of PRL-dependent cell lines up to 18-fold. CypB by itself was nonmitogenic and did not potentiate the action of GH or other interleukins. CypB did not alter the affinity of the PRL receptor (PRLr) for its ligand, or increase the phosphorylation of PRLr-associated Jak2 or Stat5a. The potentiation of PRL-action by CypB, however, was accompanied by a dramatic increase in the nuclear retrotranslocation of PRL. A CypB mutant, termed CypB-NT, was generated that lacked the wild-type N-terminal nuclear localization sequence. Although CypB-NT demonstrated levels of PRL binding and PPI activity equivalent to wild-type CypB, it was incapable of mediating the nuclear retrotranslocation of PRL or enhancing PRL-driven proliferation. These studies reveal CypB as an important chaperone facilitating the nuclear retrotransport and action of the lactogenic hormones.
Similar articles
-
Role of cyclophilins in somatolactogenic action.Ann N Y Acad Sci. 2000;917:514-21. doi: 10.1111/j.1749-6632.2000.tb05416.x. Ann N Y Acad Sci. 2000. PMID: 11268379 Review.
-
Lactogenic hormone-inducible phosphorylation and gamma-activated site-binding activities of Stat5b in primary rat Leydig cells and MA-10 mouse Leydig tumor cells.Endocrinology. 1998 Apr;139(4):1872-82. doi: 10.1210/endo.139.4.5956. Endocrinology. 1998. PMID: 9528973
-
Prolactin signal transduction to milk protein genes: carboxy-terminal part of the prolactin receptor and its tyrosine phosphorylation are not obligatory for JAK2 and STAT5 activation.Mol Cell Endocrinol. 1997 Mar 28;127(2):155-69. doi: 10.1016/s0303-7207(97)04005-7. Mol Cell Endocrinol. 1997. PMID: 9099911
-
An immunohistochemical approach to monitor the prolactin-induced activation of the JAK2/STAT5 pathway in pancreatic islets of Langerhans.J Histochem Cytochem. 2002 Mar;50(3):365-83. doi: 10.1177/002215540205000308. J Histochem Cytochem. 2002. PMID: 11850439
-
Prolactin and growth hormone signaling.Curr Top Dev Biol. 2005;68:1-23. doi: 10.1016/S0070-2153(05)68001-5. Curr Top Dev Biol. 2005. PMID: 16124994 Review.
Cited by
-
Cyclophilin inhibition as a strategy for the treatment of human disease.Front Pharmacol. 2024 Jul 8;15:1417945. doi: 10.3389/fphar.2024.1417945. eCollection 2024. Front Pharmacol. 2024. PMID: 39045055 Free PMC article. Review.
-
Management of cytoskeleton architecture by molecular chaperones and immunophilins.Cell Signal. 2011 Dec;23(12):1907-20. doi: 10.1016/j.cellsig.2011.07.023. Epub 2011 Aug 12. Cell Signal. 2011. PMID: 21864675 Free PMC article. Review.
-
Cyclophilin B as a co-regulator of prolactin-induced gene expression and function in breast cancer cells.J Mol Endocrinol. 2010 Jun;44(6):319-29. doi: 10.1677/JME-09-0140. Epub 2010 Mar 17. J Mol Endocrinol. 2010. PMID: 20237142 Free PMC article.
-
Severe osteogenesis imperfecta in cyclophilin B-deficient mice.PLoS Genet. 2009 Dec;5(12):e1000750. doi: 10.1371/journal.pgen.1000750. Epub 2009 Dec 4. PLoS Genet. 2009. PMID: 19997487 Free PMC article.
-
Cyclophilin and viruses: cyclophilin as a cofactor for viral infection and possible anti-viral target.Drug Target Insights. 2007;2:9-18. Epub 2007 Feb 5. Drug Target Insights. 2007. PMID: 21901058 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous